Identification and in vitro genotoxicity assessment of forced degradation products of glimepiride and glyburide using HEK cell‐based COMET assay
Biomedical Chromatography · 2024
DOI: 10.1002/bmc.6025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2024. Verfasst von Riya Jain und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research (NIPER) Hajipur, Bihar, India. Hauptthemen laut MEDLINE: Sulfonylurea Compounds, Glyburide, Comet Assay, Drug Contamination. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben.
Abstract (Originalsprache)
This study focuses on characterizing the forced degradation products of antidiabetic drugs glimepiride (GMD) and glyburide (GBD), with previously unexplored genotoxicity. Drugs underwent stress induced by acid, base, and hydrogen peroxide. For GMD, impurities were profiled and isolated using Hypersil Gold C8 (250 × 10 mm, 5 μ) through semi‐preparative HPLC with a fraction collector. For GBD, impurity profiling was performed using semi‐preparative HPLC (Hypersil GOLD C18, 250 × 10 mm, 5 μ), and reverse‐phase flash chromatography (FP ECOFLEX C18 4 g column) for isolation. Although five GMD and three GBD impurities were detected, only three GMD and two GBD impurities were separated and assessed for purity using analytical RP‐HPLC with the purity percentages ranging from 96.6% to 99.9%. LC‐Orbitrap MS was used to identify these three GMD impurities (m/z: 408.122, 338.340, 381.160) and two GBD impurities (m/z: 369.065, 325.283). ProTox‐II in silico predictions classified all impurities as class 4 and 5, with no positive genotoxicity indications. In vitro comet assays, using HEK cells, indicated that for GMD, impurity 2 and impurity 5 were less genotoxic, whereas impurity 4 exhibited genotoxicity. For GBD, both impurities 1 and 3 were found to be genotoxic, with impurity 3 showing a higher level of genotoxicity than impurity 1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research (NIPER) Hajipur, Bihar, India.
- Department of Biotechnology, National Institute of Pharmaceutical Education and Research (NIPER) Hajipur, Bihar, India.
ORCID-Profile: Ramalingam Peraman
Zitieren
APA
Jain, R., Aishwarya, D., Wankhade, S., Anupriya, Kumarasamy, M., & Peraman, R. (2024). Identification and in vitro genotoxicity assessment of forced degradation products of glimepiride and glyburide using HEK cell‐based COMET assay. Biomedical Chromatography. https://doi.org/10.1002/bmc.6025
Vancouver
Jain R, Aishwarya D, Wankhade S, Anupriya, Kumarasamy M, Peraman R. Identification and in vitro genotoxicity assessment of forced degradation products of glimepiride and glyburide using HEK cell‐based COMET assay. Biomedical Chromatography. 2024. doi:10.1002/bmc.6025
BibTeX
@article{Jain2024,
author = {Jain, Riya and Aishwarya, Dande and Wankhade, Shrutika and Anupriya and Kumarasamy, Murali and Peraman, Ramalingam},
title = {Identification and in vitro genotoxicity assessment of forced degradation products of glimepiride and glyburide using HEK cell‐based COMET assay},
journal = {Biomedical Chromatography},
year = {2024},
doi = {10.1002/bmc.6025}
}
EUVIMED